amador bioscience-png
Landing Page Header (2) (1)

Blog

Welcome to our NEW blog where you can explore insightful articles on the latest advances and trends for next-gen drug development.

Evaluating ADA Response Essential for Biologics Evaluating ADA Response Essential for Biologics Regulatory Recommendations for Investigating the Immune Response to Biologics
Project Optimus: Drug Development Expertise Fits New FDA Guidance Targeting Cancer Therapeutics Project Optimus: Drug Development Expertise Fits New FDA Guidance Targeting Cancer Therapeutics Drug Development Expertise Fits New FDA Guidance Targeting Cancer Therapeutics
Estimation of Body Fat Percentagefor Clinical Pharmacokinetic Studies in Children Estimation of Body Fat Percentagefor Clinical Pharmacokinetic Studies in Children 🚨Publication Alert 🚨 Check out this week's publication in Clinical and Translational science from the ASCPT Journal Family. 📃Read it ...
Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread Monoclonal Antibody Treatment,Prophylaxis and Vaccines Combined to Reduce SARS CoV-2Spread 🚨Publication Alert🚨 This week's publication is from Dr. Nidal Al-Huniti, President of Clinical Pharmacology at Amador Bioscience. 📃Read ...
High-sensitivity quantification ofantisense oligonucleotides forpharmacokinetic characterization High-sensitivity quantification ofantisense oligonucleotides forpharmacokinetic characterization 🚨Publication Alert🚨 Check out this research lead by our CTO and President of Bioanalysis & Biomarkers, Meina Liang. In this ...

Sign up to receive our latest updates via email!

Let's stay in touch.